Evaluation of the efficacy of intravenous iron III-hydroxide saccharate for treating adult patients with iron deficiency anemia;Avaliação da eficácia do uso intravenoso de sacarato de hidróxido de ferro III no tratamento de pacientes adultos com anemia ferropriva

Revista Brasileira de Hematologia e Hemoterapia

Volumn 29, Issue 2, 2007, Pages 123-129

  Cançado, Rodolfo Delfini ^a,b   Brasil, Sérgio A B ^a   Noronha, Tatiana G ^a   Chiattone, Carlos S ^b  

^a FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^b Hemocentro da Santa Casa de São Paulo ^*  (Brazil)

Author keywords

Intravenous iron; Iron deficiency anemia; Iron III hydroxide saccharate

Indexed keywords

EID: 37349124650     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-84842007000200009     Document Type: Article

References (16)

1. Looker AC, Dallman PR, Carroll MD, et al. Prevalence of iron deficiency in the United States. JAMA. 1997;277:973-6.
2. Guerra CCC, Guerra JCC. Anemias carenciais. Rev Bras Med. 1997;53:78:106.
3. Gualandro SFM, Cliquet MG, Silveira PAA, et al. Deficiência de ferro em doadoras de sangue da Fundação Pró-sangue/ Hemocentro de São Paulo. Ser. Monogr. Esc Bras Hematol 1999;6(supl):8. [Resumo].
4. Cançado RD, Alonso FA, Langhi DM Jr, et al. Iron Deficiency in blood donors. São Paulo Med J. 2001;4:132-34.
5. Chiattone CS. Avaliação prospectiva de variáveis hematológicas em pacientes portadores de úlcera péptica submetidos a ressecção gástrica. São Paulo, 1988. (Tese - Mestrado - Escola Paulista de Medicina).
6. Andrews N. Disorders of iron metabolism. N Engl J Med. 1999;23:1986-95.
7. Lee GR. Iron deficiency and iron-deficiency anemia. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN, editors. Wintrobe's Clinical Hematology. 9th ed. Philadelphia-London: Lea & Febiger Press; 1993. p.808-839.
8. Cook JD. Newer aspects of the diagnosis and treatment of iron deficiency. Hematology. 2003;53-61.
9. Gandler G, Harchowal J, Macdougall IC. Intravenous iron sucrose: establishing a safe dose. Am J Kidney Dis. 2001;38:988-91.
10. Danielson BG, Salmonson T, Derendorf H, Geisser P. Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers. Arzneimittelforschung. 1996;46(6):615-21.
11. Faich G, Strobos J. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans. Am J Kidney Dis. 1999;33:464-79.
12. Frankenfield DL, Johnson CA. Current management of anemia in adult hemodialysis patients with end-stage renal disease. Am J Health Syst Pharm. 2002;59:429-35.
13. Panesar A, Agarwal R. Safety and efficacy of sodium ferric gluconate complex in patients with chronic kidney disease. Am J Kidney Dis. 2002;40:924-31.
14. Reynoso-Gomez E, Salinas-Rojas V, Lazo-Langner A. Safety and efficacy of total dose intravenous iron infusion in the treatment of iron-deficiency anemia in adult non-pregnant patients. Rev Invest Clin. 2002;54:12-20.
15. Surico G, Muggeo P, Muggeo V, et al. Parenteral iron supplementation for the treatment of iron deficiency anemia in children. Ann Hematol. 2002;81:154-7.
16. Breymann C, Visca E, Huch R, et al. Efficacy and safety of intravesnously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy. Am J Obstet Gynecol 2001;184:662-7.